5-HT2A receptor antagonists (Angelini Pharmaceuticals)
N/A
Report date: 2025/02/01 20:00:06
NME
Base Information
Drug Name5-HT2A receptor antagonists (Angelini Pharmaceuticals)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[2]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAngelini Pharma SPA
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAngelini Pharma SPA
Active IndicationsN/A
Inactive Indications +[2]
Other Information
ATC CodeN/A
Related LinksN/A